{"title": "Comprender la inmunidad a las vacunas COVID-19", "author": "Kari Christine Nadeau; MD; PhD", "url": "https://ichgcp.net/es/clinical-trials-registry/NCT04664309", "hostname": "ichgcp.net", "description": "El prop\u00f3sito de este estudio es probar la inmunidad a lo largo del tiempo a las vacunas COVID-19. Se invitar\u00e1 a participar a los adultos que est\u00e9n recibiendo la.... Registro de ensayos cl\u00ednicos. ICH GCP.", "sitename": "ichgcp.net", "date": "2020-12-09", "id": null, "license": null, "body": null, "comments": "", "commentsbody": null, "raw_text": null, "text": "Comprender la inmunidad a las vacunas COVID-19\n9 de febrero de 2022 actualizado por: Kari Christine Nadeau, MD, PhD,\n[Stanford University](https://ichgcp.net/es/clinical-trials-registry/research/list?spons=Stanford%20University)\nEl prop\u00f3sito de este estudio es probar la inmunidad a lo largo del tiempo a las vacunas COVID-19. Se invitar\u00e1 a participar a los adultos que est\u00e9n recibiendo las vacunas contra el COVID-19.\nDescripci\u00f3n general del estudio\nEstado\nTerminado\nIntervenci\u00f3n / Tratamiento\nTipo de estudio\nDe observaci\u00f3n\nInscripci\u00f3n (Actual)\n43\nContactos y Ubicaciones\nEsta secci\u00f3n proporciona los datos de contacto de quienes realizan el estudio e informaci\u00f3n sobre d\u00f3nde se lleva a cabo este estudio.\nUbicaciones de estudio\n-\nEstados Unidos\n-\nCalifornia\n-\nStanford, California, Estados Unidos, 94305\n- Stanford University, Hospital, and Clinics\n-\n-\nCriterios de participaci\u00f3n\nLos investigadores buscan personas que se ajusten a una determinada descripci\u00f3n, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.\nCriterio de elegibilidad\nEdades elegibles para estudiar\n18 a\u00f1os y mayores (Adulto, Adulto Mayor)\nAcepta Voluntarios Saludables\nNo\nG\u00e9neros elegibles para el estudio\nTodos\nM\u00e9todo de muestreo\nMuestra no probabil\u00edstica\nPoblaci\u00f3n de estudio\nAdultos (mayores de 18 a\u00f1os) que reciben una vacuna contra el COVID-19\nDescripci\u00f3n\nCriterios de inclusi\u00f3n:\n- Adultos que est\u00e1n recibiendo una vacuna COVID-19\nCriterio de exclusi\u00f3n:\n- Pacientes con riesgos especiales relacionados con la venopunci\u00f3n\nPlan de estudios\nEsta secci\u00f3n proporciona detalles del plan de estudio, incluido c\u00f3mo est\u00e1 dise\u00f1ado el estudio y qu\u00e9 mide el estudio.\n\u00bfC\u00f3mo est\u00e1 dise\u00f1ado el estudio?\nDetalles de dise\u00f1o\n- Modelos observacionales: Solo caso\n- Perspectivas temporales: Futuro\nCohortes e Intervenciones\n|\n|\nGrupo / Cohorte\n|\n|\nIntervenci\u00f3n / Tratamiento\n|\n|\nParticipantes\nAdultos que est\u00e1n recibiendo una vacuna COVID-19\n|\n|\nSin intervenci\u00f3n\n\u00bfQu\u00e9 mide el estudio?\nMedidas de resultado primarias\n|\n|\nMedida de resultado\n|\n|\nPeriodo de tiempo\n|\n|\nPorcentaje de participantes con inmunidad a las vacunas COVID-19 a lo largo del tiempo\nPeriodo de tiempo: 1 a\u00f1o\n|\n|\n1 a\u00f1o\nColaboradores e Investigadores\nAqu\u00ed es donde encontrar\u00e1 personas y organizaciones involucradas en este estudio.\nPatrocinador\nColaboradores\nFechas de registro del estudio\nEstas fechas rastrean el progreso del registro del estudio y los env\u00edos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los est\u00e1ndares de control de calidad espec\u00edficos antes de publicarlos en el sitio web p\u00fablico.\nFechas importantes del estudio\nInicio del estudio (Actual)\n26 de marzo de 2021\nFinalizaci\u00f3n primaria (Actual)\n6 de enero de 2022\nFinalizaci\u00f3n del estudio (Actual)\n6 de enero de 2022\nFechas de registro del estudio\nEnviado por primera vez\n9 de diciembre de 2020\nPrimero enviado que cumpli\u00f3 con los criterios de control de calidad\n9 de diciembre de 2020\nPublicado por primera vez (Actual)\n11 de diciembre de 2020\nActualizaciones de registros de estudio\n\u00daltima actualizaci\u00f3n publicada (Actual)\n28 de febrero de 2022\n\u00daltima actualizaci\u00f3n enviada que cumpli\u00f3 con los criterios de control de calidad\n9 de febrero de 2022\n\u00daltima verificaci\u00f3n\n1 de febrero de 2022\nM\u00e1s informaci\u00f3n\nT\u00e9rminos relacionados con este estudio\nT\u00e9rminos MeSH relevantes adicionales\nOtros n\u00fameros de identificaci\u00f3n del estudio\n- IRB-60171\nPlan de datos de participantes individuales (IPD)\n\u00bfPlanea compartir datos de participantes individuales (IPD)?\nNo\nInformaci\u00f3n sobre medicamentos y dispositivos, documentos del estudio\nEstudia un producto farmac\u00e9utico regulado por la FDA de EE. UU.\nNo\nEstudia un producto de dispositivo regulado por la FDA de EE. UU.\nNo\nEsta informaci\u00f3n se obtuvo directamente del sitio web\n[clinicaltrials.gov](https://clinicaltrials.gov) sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comun\u00edquese con [register@clinicaltrials.gov](mailto:register@clinicaltrials.gov). Tan pronto como se implemente un cambio en [clinicaltrials.gov](https://clinicaltrials.gov), tambi\u00e9n se actualizar\u00e1 autom\u00e1ticamente en nuestro sitio web. .\nEnsayos cl\u00ednicos sobre COVID-19\n-\nNCT06042530ReclutamientoDeterioro Cognitivo | Condici\u00f3n posterior a COVID-19 | Fatiga Mental\n-\nNCT06039449Reclutamiento\n-\nNCT06038617A\u00fan no reclutandoFiebre | Fiebre despu\u00e9s de la vacunaci\u00f3n | Convulsiones Fiebre\n-\nNCT06038682Reclutamiento\n-\nNCT06036134A\u00fan no reclutandoSalud Conocimiento, Actitudes, Pr\u00e1ctica | Pandemia de COVID-19 | Enfermedades prevenibles por vacunaci\u00f3n | Comportamiento relacionado con la salud | Narraci\u00f3n\n-\nNCT06036251A\u00fan no reclutandoEstr\u00e9s | Estr\u00e9s, Emocional | Pandemia de COVID-19 | Reacci\u00f3n de estr\u00e9s\n-\nNCT06030414A\u00fan no reclutando\n-\nNCT06032000A\u00fan no reclutando\n[Un estudio de fase 1 para evaluar la seguridad, reactogenicidad e inmunogenicidad de una vacuna de refuerzo contra el SARS-CoV-2 (LEM-mR203) en adultos sanos](https://ichgcp.net/es/clinical-trials-registry/NCT06032000)Contagio de COVID-19 | Reacci\u00f3n adversa a la vacuna COVID-19\n-\nNCT06027229A\u00fan no reclutando\n[Inmunogenicidad humoral y celular recombinante adicional de COVID-19 en poblaciones inmunodeprimidas](https://ichgcp.net/es/clinical-trials-registry/NCT06027229)COVID-19 | Inmunosupresi\u00f3n\n-\nNCT06027255A\u00fan no reclutandoCOVID largo | Disfunci\u00f3n auton\u00f3mica | POTS - S\u00edndrome de taquicardia ortost\u00e1tica postural\nEnsayos cl\u00ednicos sobre Sin intervenci\u00f3n\n-\nNCT06038994ReclutamientoInfarto de miocardio agudo\n-\nNCT06039982A\u00fan no reclutandoCarcinoma de cuello uterino\n-\nNCT06039800Reclutamiento\n-\nNCT06037304ReclutamientoHernia Inguinal\n-\nNCT06037057A\u00fan no reclutando\n[Aplicaci\u00f3n de la tecnolog\u00eda de aprendizaje profundo de inteligencia artificial en im\u00e1genes lumbares por resonancia magn\u00e9tica](https://ichgcp.net/es/clinical-trials-registry/NCT06037057)Aprendizaje profundo, im\u00e1genes por resonancia magn\u00e9tica lumbar\n-\nNCT06034145A\u00fan no reclutando\n[Prueba de provocaci\u00f3n con metacolina: comparaci\u00f3n de los par\u00e1metros FEV1 e IOS en pacientes adultos con asma](https://ichgcp.net/es/clinical-trials-registry/NCT06034145)Hiperreactividad bronquial\n-\nNCT06034509A\u00fan no reclutandoLesi\u00f3n cerebral traum\u00e1tica | Demencia vascular | Deterioro cognitivo\n-\nNCT06030323Reclutamiento\n-\nNCT06032091A\u00fan no reclutando\n-\nNCT06031896A\u00fan no reclutandoEnfermedades periodontales", "language": null, "image": null, "pagetype": "website", "links": ["https://ichgcp.net/es", "#", "https://ichgcp.net/de", "https://ichgcp.net/", "https://ichgcp.net/es", "https://ichgcp.net/fr", "https://ichgcp.net/it", "https://ichgcp.net/pt", "https://ichgcp.net/ru", "https://ichgcp.net/es/guidance-for-industry-investigator-responsibilities-protecting-the-rights-safety-and-welfare-of-study-subjects", "https://ichgcp.net/es/guidance-for-the-notification-of-serious-breaches-of-gcp-or-the-trial-protocol", "https://ichgcp.net/es/national-statement-on-ethical-conduct-in-human-research-2007-updated-2018-nhmrc-australia", "https://ichgcp.net/es/ministerial-ordinance-on-good-clinical-practice-for-drugs-pharmaceuticals-and-medical-devices-agency-japan", "https://ichgcp.net/es/ich-e-group-of-guidelines", "https://ichgcp.net/es/cro-list", "https://ichgcp.net/es/clinical-trials-registry", "https://ichgcp.net/es/eu-clinical-trials-registry", "https://ichgcp.net/es/pharma-list", "https://ichgcp.net/es/labs", "https://ichgcp.net/es/service-companies", "https://ichgcp.net/es/events", "https://ichgcp.net/es/clinical-trials-registry/publications", "https://ichgcp.net/es/clinical-trials-registry/researchers", "https://ichgcp.net/es/cra-jobs", "https://ichgcp.net/es/publications", "https://ichgcp.net/es/news", "https://ichgcp.net/clinical-trials-registry/NCT04664309", "https://telegram.me/share/url?url=https://ichgcp.net/es/clinical-trials-registry/NCT04664309&text=", "https://twitter.com/intent/tweet?url=https://ichgcp.net/es/clinical-trials-registry/NCT04664309", "https://ichgcp.net/es", "https://ichgcp.net/es/clinical-trials-registry", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=Stanford%20University", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=COVID-19", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Immunity", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Vaccine", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=No%20intervention", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=No%20intervention", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=Stanford%20University", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=National%20Institutes%20of%20Health%20%28NIH%29", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Coronavirus%20Infections", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Coronaviridae%20Infections", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Nidovirales%20Infections", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=RNA%20Virus%20Infections", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Virus%20Diseases", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Infections", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Respiratory%20Tract%20Infections", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Respiratory%20Tract%20Diseases", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Pneumonia%2C%20Viral", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Pneumonia", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Lung%20Diseases", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=COVID-19", "https://clinicaltrials.gov", "mailto:register@clinicaltrials.gov", "https://clinicaltrials.gov", "https://ichgcp.net/es/clinical-trials-registry/NCT06042530", "https://ichgcp.net/es/clinical-trials-registry/NCT06039449", "https://ichgcp.net/es/clinical-trials-registry/NCT06038617", "https://ichgcp.net/es/clinical-trials-registry/NCT06038682", "https://ichgcp.net/es/clinical-trials-registry/NCT06036134", "https://ichgcp.net/es/clinical-trials-registry/NCT06036251", "https://ichgcp.net/es/clinical-trials-registry/NCT06030414", "https://ichgcp.net/es/clinical-trials-registry/NCT06032000", "https://ichgcp.net/es/clinical-trials-registry/NCT06027229", "https://ichgcp.net/es/clinical-trials-registry/NCT06027255", "https://ichgcp.net/es/clinical-trials-registry/NCT06038994", "https://ichgcp.net/es/clinical-trials-registry/NCT06039982", "https://ichgcp.net/es/clinical-trials-registry/NCT06039800", "https://ichgcp.net/es/clinical-trials-registry/NCT06037304", "https://ichgcp.net/es/clinical-trials-registry/NCT06037057", "https://ichgcp.net/es/clinical-trials-registry/NCT06034145", "https://ichgcp.net/es/clinical-trials-registry/NCT06034509", "https://ichgcp.net/es/clinical-trials-registry/NCT06030323", "https://ichgcp.net/es/clinical-trials-registry/NCT06032091", "https://ichgcp.net/es/clinical-trials-registry/NCT06031896", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=Jos%25C3%25A9phine%2BSOLTANI%252C%2BCardiology%2Bdepartment%252C%2BVersailles%2BHospital", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=SeeCure%2BLLC", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=Novartis%2BPharmaceuticals", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=AstraZeneca", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=European%2BSociety%2Bof%2BHuman%2BReproduction%2Band%2BEmbryology", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=Universidade%2Bde%2BLisboa%252C%2BPortugal", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=National%2BCancer%2BInstitute%2B%2528NCI%2529", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=Universidad%2Bdel%2BZulia", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=Pfizer", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=Kaneka%2BAmericas%2BHolding%2BInc.", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=Assiut%2BUniversity", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=Cairo%2BUniversity", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=Medtronic%2BSurgical%2BTechnologies", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=Orphanetics%2BPharma%2BEntwicklungs%2BGmbH", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=Mayo%2BClinic", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=Center%2Bfor%2BIndustrial%2BTechnological%2BDevelopment%2Bof%2BSpain", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=M.D.%2BAnderson%2BCancer%2BCenter", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=GlaxoSmithKline", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=Pediatric%2BOrthopaedic%2BSociety%2Bof%2BNorth%2BAmerica", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=Assistance%2BPublique%2B-%2BH%25C3%25B4pitaux%2Bde%2BParis", "https://ichgcp.net/es/clinical-trials-registry/research/browse/spns_alpha_all", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Pain", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Ultrasound%2BEvaluation", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Postneoadjuvant%2BTherapy%2BStage%2BI%2BGastric%2BCancer%2BAJCC%2Bv8", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=HIV%2BInfections", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Carcinoma%252C%2BAdrenal%2BCortical", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Esophageal%2BResection%2BCandidates", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Stroke", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Hypertension", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Prostate%2BCancer", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Asthma", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Stage%2BI%2BGallbladder%2BCancer%2BAJCC%2Bv8", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Colon%2BMalignant%2BTumor", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Depression", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Cushing%2527s%2BSyndrome%2BI", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Obesity", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Ankle%2BArthroplasty", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Breast%2BCancer", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Coronary%2BArtery%2BDisease", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Malignant%2BNeoplasm%2Bof%2BRespiratory%2Band%2BIntrathoracic%2BOrgan%2BCarcinoma", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Post-traumatic%2BAnosmia", "https://ichgcp.net/es/clinical-trials-registry/research/browse/cond_alpha_all", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Paclitaxel", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=MK-8521%2B100%25CE%25BCg", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Oral%2BGlucose%2BGel", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Teicoplanin%2BSandoz%2B200%2Bmg%2Bpowder%2Band%2Bsolvent%2Bfor%2Bsolution%2Bfor%2Binjection%2Bor%2Binfusion%2Bor%2Boral%2Bsolution.", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Docetaxel", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Transplant%2B2%2BMelphalan", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Gemcitabine", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Alpelisib%2B150%2BMG%2BOral%2BTablet%2B%255BPiqray%255D", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Capecitabine", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Prednisone", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Pilocarpine%2B1.25%2525%2BEye%2Bdrop", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Cisplatin", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Dexamethasone", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Injectafer", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Carboplatin", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Brimonidine%2Btartrate%2Bophthalmic%2Bsolution%2B0.025%2525%2B%2528n%2B%253D%2B56%2529", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Cyclophosphamide", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Valacyclovir%2Barrow", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=20mg%2BAzilsartan%2BTablets", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Bevacizumab", "https://ichgcp.net/es/clinical-trials-registry/research/browse/intr_alpha_all", "https://ichgcp.net/es/cro-list/country/cambodia", "https://ichgcp.net/es/cro-list/country/canada", "https://ichgcp.net/es/cro-list/country/djibouti", "https://ichgcp.net/es/cro-list/country/guinea", "https://ichgcp.net/es/cro-list/country/lithuania", "https://ichgcp.net/es/cro-list/country/morocco", "https://ichgcp.net/es/cro-list/country/mozambique", "https://ichgcp.net/es/cro-list/country/romania", "https://ichgcp.net/es/cro-list/country/saudi_arabia", "https://ichgcp.net/es/cro-list/country/sri_lanka", "https://ichgcp.net/es/cro-list/country/switzerland", "https://ichgcp.net/es/cro-list/country/usa", "https://ichgcp.net/es/cro-list/country/vietnam", "https://ichgcp.net/es/cro-list", "https://ichgcp.net/es/cro-list/country/slovakia/company/labcorp_drug_development", "https://ichgcp.net/es/cro-list/country/slovakia/company/iqvia", "https://ichgcp.net/es/cro-list/country/slovakia/company/ppd", "https://ichgcp.net/es/cro-list/country/slovakia/company/clinitria", "https://ichgcp.net/es/cro-list/country/slovakia/company/sanaclis", "https://ichgcp.net/es/cro-list/country/slovakia/company/psi", "https://ichgcp.net/es/cro-list/country/slovakia/company/pra_health_sciences", "https://ichgcp.net/es/cro-list/country/slovakia/company/emmes", "https://ichgcp.net/es/cro-list/country/slovakia/company/premier_research", "https://ichgcp.net/es/cro-list/country/slovakia/company/sgs", "https://ichgcp.net/es/cro-list/country/slovakia", "https://ichgcp.net/es/clinical-trials-registry/research/browse/cond_alpha_all", "https://ichgcp.net/es/clinical-trials-registry/research/browse/cond_cat", "https://ichgcp.net/es/clinical-trials-registry/research/browse/ord_alpha_all", "https://ichgcp.net/es/clinical-trials-registry/research/browse/intr_alpha_all", "https://ichgcp.net/es/clinical-trials-registry/research/browse/intr_cat", "https://ichgcp.net/es/clinical-trials-registry/research/browse/diet_alpha_all", "https://ichgcp.net/es/clinical-trials-registry/research/browse/diet_cat", "https://ichgcp.net/es/clinical-trials-registry/research/browse/spns_alpha_all", "https://ichgcp.net/es/clinical-trials-registry/research/browse/spns_cat", "https://ichgcp.net/es/clinical-trials-registry/research/browse/locn_alpha_all", "https://ichgcp.net/es/clinical-trials-registry/research/browse/locn_cat", "https://ichgcp.net/es", "https://ichgcp.net/es/guidance-for-industry-investigator-responsibilities-protecting-the-rights-safety-and-welfare-of-study-subjects", "https://ichgcp.net/es/guidance-for-the-notification-of-serious-breaches-of-gcp-or-the-trial-protocol", "https://ichgcp.net/es/national-statement-on-ethical-conduct-in-human-research-2007-updated-2018-nhmrc-australia", "https://ichgcp.net/es/ministerial-ordinance-on-good-clinical-practice-for-drugs-pharmaceuticals-and-medical-devices-agency-japan", "https://ichgcp.net/es/guideline-for-the-notification-of-serious-breaches-of-regulation-eu-no-536-2014", "https://ichgcp.net/es/cro-list", "https://ichgcp.net/es/pharma-list", "https://ichgcp.net/es/labs", "https://ichgcp.net/es/service-companies", "https://ichgcp.net/es/cra-jobs", "https://ichgcp.net/es/clinical-trials-registry", "https://ichgcp.net/es/eu-clinical-trials-registry", "https://ichgcp.net/es/publications", "https://ichgcp.net/es/news", "https://ichgcp.net/about-us-our-mission", "https://ichgcp.net/es/sitemap", "https://ichgcp.net/es/contact-us", "https://ichgcp.net/es/feed", "/privacy", "/disclaimer", "https://ichgcp.net/da/clinical-trials-registry/NCT04664309", "https://ichgcp.net/de/clinical-trials-registry/NCT04664309", "https://ichgcp.net/clinical-trials-registry/NCT04664309", "https://ichgcp.net/es/clinical-trials-registry/NCT04664309", "https://ichgcp.net/fr/clinical-trials-registry/NCT04664309", "https://ichgcp.net/it/clinical-trials-registry/NCT04664309", "https://ichgcp.net/hu/clinical-trials-registry/NCT04664309", "https://ichgcp.net/nl/clinical-trials-registry/NCT04664309", "https://ichgcp.net/no/clinical-trials-registry/NCT04664309", "https://ichgcp.net/pl/clinical-trials-registry/NCT04664309", "https://ichgcp.net/pt/clinical-trials-registry/NCT04664309", "https://ichgcp.net/fi/clinical-trials-registry/NCT04664309", "https://ichgcp.net/sv/clinical-trials-registry/NCT04664309", "https://ichgcp.net/cs/clinical-trials-registry/NCT04664309", "https://ichgcp.net/ru/clinical-trials-registry/NCT04664309", "https://ichgcp.net/ja/clinical-trials-registry/NCT04664309", "https://ichgcp.net/zh/clinical-trials-registry/NCT04664309", "https://ichgcp.net/ko/clinical-trials-registry/NCT04664309", "https://ichgcp.net/pdf/privacy_cookies_policy.pdf", "https://ichgcp.net/pdf/terms_of_service.pdf", "https://ichgcp.net/pdf/privacy_cookies_policy.pdf", "https://ichgcp.net/pdf/terms_of_service.pdf"]}